Human papillomavirus (HPV) vaccine coverage achievements in low and middle-income countries 2007â2016
Introduction: Since 2007, HPV vaccine has been available to low and middle income countries (LAMIC) for small-scale âdemonstration projectsâ, or national programmes. We analysed coverage achieved in HPV vaccine demonstration projects and national programmes that had completed at least 6 months of im...
Main Authors: | Katherine E. Gallagher, Natasha Howard, Severin Kabakama, Sandra Mounier-Jack, Helen E.D. Burchett, D. Scott LaMontagne, Deborah Watson-Jones |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2017-12-01
|
Series: | Papillomavirus Research |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2405852117300320 |
Similar Items
-
What works for human papillomavirus vaccine introduction in low and middle-income countries?
by: Natasha Howard, et al.
Published: (2017-12-01) -
Lessons learnt from human papillomavirus (HPV) vaccination in 45 low- and middle-income countries.
by: Katherine E Gallagher, et al.
Published: (2017-01-01) -
Social mobilisation, consent and acceptability: a review of human papillomavirus vaccination procedures in low and middle-income countries
by: Severin Kabakama, et al.
Published: (2016-08-01) -
Vaccine programme stakeholder perspectives on a hypothetical single-dose human papillomavirus (HPV) vaccine schedule in low and middle-income countries
by: Katherine E. Gallagher, et al.
Published: (2018-12-01) -
Perceptions and Experiences of Human Papillomavirus (HPV) Infection and Testing among Low-Income Mexican Women.
by: Leith León-Maldonado, et al.
Published: (2016-01-01)